Lori Calabrese, MD


Founder and Director of Innovative Psychiatry, and a clinician innovator who's published fresh data using ketamine infusions to stop suicidality in the office, and just last month, a novel sequenced ketamine treatment which produced complete remission and recovery in anorexia. She has been invited to present her clinical results using IV ketamine treatment at several national and international conferences, including the American Psychiatric Association, International Association for Suicide Research and the American Suicide Foundation International Research Summit on Suicide, the American Association of Suicidology, KRIYA Conference, the American Society of Ketamine Physicians, Ketamine and Related Compounds Oxford UK, and Ketamine 2021: Oxford and OnLine Conference